Literature DB >> 16110007

Gefitinib in colorectal cancer: if wishes were horses.

Charles D Blanke.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16110007     DOI： 10.1200/JCO.2005.05.904

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  6 in total

1.  Synergistic induction of apoptosis by salinomycin and gefitinib through lysosomal and mitochondrial dependent pathway overcomes gefitinib resistance in colorectal cancer.

Authors:  Zheng-Zhi Zou; Pei-Pei Nie; Ya-Wei Li; Ben-Xin Hou; Xin-Peng Shi; Zhao-Kui Ma; Bao-Wei Han; Xiao-Yong Luo
Journal:  Oncotarget       Date:  2017-04-04

2.  LGR5 expression is regulated by EGF in early colorectal adenomas and governs EGFR inhibitor sensitivity.

Authors:  R G Morgan; E Mortensson; D N Legge; B Gupta; T J Collard; A Greenhough; A C Williams
Journal:  Br J Cancer       Date:  2017-11-16       Impact factor: 7.640

3.  Enhancement by Nano-Diamino-Tetrac of Antiproliferative Action of Gefitinib on Colorectal Cancer Cells: Mediation by EGFR Sialylation and PI3K Activation.

Authors:  Tung-Cheng Chang; Yu-Tang Chin; André Wendindondé Nana; Shwu-Huey Wang; Yu-Min Liao; Yi-Ru Chen; Ya-Jung Shih; Chun A Changou; Yu-Chen Sh Yang; Kuan Wang; Jacqueline Whang-Peng; Liang-Shun Wang; Steven C Stain; Ai Shih; Hung-Yun Lin; Chih-Hsiung Wu; Paul J Davis
Journal:  Horm Cancer       Date:  2018-09-05       Impact factor: 3.869

Review 4.  Role of thyroid hormone-integrin αvβ3-signal and therapeutic strategies in colorectal cancers.

Authors:  Yu-Chen S H Yang; Po-Jui Ko; Yi-Shin Pan; Hung-Yun Lin; Jacqueline Whang-Peng; Paul J Davis; Kuan Wang
Journal:  J Biomed Sci       Date:  2021-04-08       Impact factor: 8.410

5.  MiR-323a regulates ErbB3/EGFR and blocks gefitinib resistance acquisition in colorectal cancer.

Authors:  Yuanzhou Zhang; Shunshun Liang; Bowen Xiao; Jingying Hu; Yechun Pang; Yuling Liu; Juan Yang; Junpin Ao; Lin Wei; Xiaoying Luo
Journal:  Cell Death Dis       Date:  2022-03-22       Impact factor: 8.469

6.  NDAT Targets PI3K-Mediated PD-L1 Upregulation to Reduce Proliferation in Gefitinib-Resistant Colorectal Cancer.

Authors:  Tung-Yung Huang; Tung-Cheng Chang; Yu-Tang Chin; Yi-Shin Pan; Wong-Jin Chang; Feng-Cheng Liu; Ema Dwi Hastuti; Shih-Jiuan Chiu; Shwu-Huey Wang; Chun A Changou; Zi-Lin Li; Yi-Ru Chen; Hung-Ru Chu; Ya-Jung Shih; R Holland Cheng; Alexander Wu; Hung-Yun Lin; Kuan Wang; Jacqueline Whang-Peng; Shaker A Mousa; Paul J Davis
Journal:  Cells       Date:  2020-08-03       Impact factor: 6.600
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.